AOP Health: Bianca Tan Assuming New Position as Therapeutic Area Director Cardiology and Pulmonology
In 2006, Bianca Tan started her career at AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company with headquarters in Vienna that specializes in rare diseases and intensive care medicine. She has worked in various departments within Research & Development since 2008, most recently as Head of Clinical Operations and Medical Device Development. In the fall of 2023, the 40-year-old took over as Therapeutic Area Director Cardiology and Pulmonology.
Due to her many years of experience at AOP Health, Tan is well-equipped in terms of extensive knowledge and expertise. In her new role, she will work closely with her team to develop strategic concepts to ensure successful positioning of the company's cardiology and pulmonology products in various markets. Her responsibilities include the development of strategies for scientific projects, positioning against competitors, and the development of marketing concepts. In doing so, she places particular emphasis on a profound understanding of the challenges and needs of existing and potential new markets as well as stakeholders, including patients and doctors.
BIANCA TAN, MSCTHERAPEUTIC AREA DIRECTOR CARDIOLOGY & PULMONOLOGY
“My main role at HQ is to provide the necessary support for our colleagues in other countries and to set the strategic direction that will guarantee they can operate successfully, because cooperation with our country subsidiaries and subcompanies is of great importance to achieve our goals and to ensure the best possible care for our stakeholders", explains Tan.
About AOP Health
The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”). The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions operating from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. The claim “Needs. Science. Trust.” sums up the foundation of the Group’s success: establishing trust through a continually high level of investment in research and development and a highly consistent and pragmatic orientation towards the needs of all stakeholders – especially the patients and their families as well as the healthcare professionals treating them.
Press contact for queries
DI Isolde Fally